Synthesis and Biological Evaluation of New 3,4-diarylmaleimides as Enhancers (modulators) of Doxorubicin Cytotoxic Activity on Cultured Tumor Cells from a Real Case of Breast Cancer

Authors

  • Jessica R. Gutierrez-Cano Universidad de Guanajuato
  • Pradip D. Nahide Universidad de Guanajuato
  • Velayudham Ramadoss Universidad de Guanajuato
  • Yuvraj Satkar Universidad de Guanajuato
  • Rafael Ortiz-Alvarado Universidad Michoacana de San Nicolás de Hidalgo
  • Clara Alba-Betancourt Universidad de Guanajuato
  • Claudia L. Mendoza-Macías Universidad de Guanajuato
  • César R. Solorio-Alvarado Universidad de Guanajuato

DOI:

https://doi.org/10.29356/jmcs.v61i1.126

Keywords:

Breast cancer, Maleimide, Doxorubicin, synergistic cancer treatment

Abstract

A series of new 3,4-diarylmaleimides were synthesized in an optimized and efficient lineal sequence of three steps, starting from commercial maleimide. The biological evaluation of these compounds as enhancers (activity modulators) in the co-administration with doxorubicin treatment in breast cancer cells directly obtained from a patient, were essayed. The cancerous tissue BT026-512N was provided by the National Institute of Cancerology (INCAN) of México. This tissue was obtained by biopsy from a patient diagnosed with stage IIB ductal breast cancer. The results obtained in the assays, show decreased cell viability on the cultured cells for all of the maleimides synthesized in combinatorial administration with doxorubicin. The highest mortality effect was determined for maleimides 9 and 29 increased in close to three times the effect compared with treatment using only doxorubicin. Based on previous functionalized maleimides core reports and Molinspiration chemoinformatic analysis, these results could possibly point out to the Pg-p glycoprotein as bio-molecular action target of maleimides by kinase phosphorylation-inhibition, although more experimental data is necessary.

Downloads

Download data is not yet available.

Author Biographies

Jessica R. Gutierrez-Cano, Universidad de Guanajuato

Departamento de Química, División de Ciencias Naturales y Exactas, Campus Guanajuato

Pradip D. Nahide, Universidad de Guanajuato

Departamento de Química, División de Ciencias Naturales y Exactas, Campus Guanajuato

Velayudham Ramadoss, Universidad de Guanajuato

Departamento de Química, División de Ciencias Naturales y Exactas, Campus Guanajuato

Yuvraj Satkar, Universidad de Guanajuato

Departamento de Química, División de Ciencias Naturales y Exactas, Campus Guanajuato

Rafael Ortiz-Alvarado, Universidad Michoacana de San Nicolás de Hidalgo

Facultad de Químico Farmacobiología

Clara Alba-Betancourt, Universidad de Guanajuato

Departamento de Farmacia, División de Ciencias Naturales y Exactas, Campus Guanajuato

Claudia L. Mendoza-Macías, Universidad de Guanajuato

Departamento de Farmacia, División de Ciencias Naturales y Exactas, Campus Guanajuato

César R. Solorio-Alvarado, Universidad de Guanajuato

Departamento de Farmacia, División de Ciencias Naturales y Exactas, Campus Guanajuato

Downloads

Published

2017-10-12

Issue

Section

Regular Articles